Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine

J Antimicrob Chemother. 2003 Aug;52(2):308-11. doi: 10.1093/jac/dkg346. Epub 2003 Jul 15.

Abstract

Objective: The objective of this study was to compare the effect of clindamycin on the intestinal microflora in subjects ingesting yogurt with added probiotic microorganisms with the microflora in subjects ingesting placebo yogurt.

Materials and methods: Twenty-four healthy subjects were included in the study. All subjects received 150 mg clindamycin four times daily for 7 days and 250 ml yogurt twice daily for 14 days. Faecal samples were collected before, during and after administration of clindamycin.

Results: In the aerobic intestinal microflora, the numbers of enterococci increased after treatment in both groups, whereas other Gram-positive microorganisms decreased. In both groups, the numbers of Escherichia coli also decreased, whereas there was a concomitant increase in numbers of other Gram-negative bacilli. In the anaerobic microflora in subjects receiving yogurt with added microorganisms, the numbers of lactobacilli and bacteroides remained at the same levels throughout the study, whereas the numbers decreased in the placebo group. Other anaerobic bacteria decreased in both groups. The minimum inhibitory concentration of clindamycin against strains of bacteroides increased in both groups during the study.

Conclusions: The probiotic microorganisms evaluated in this study prevented ecological disturbances in the numbers of intestinal Bacteroides fragilis group species during clindamycin administration.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology*
  • Bacteroides fragilis / drug effects*
  • Bacteroides fragilis / growth & development*
  • Bacteroides fragilis / isolation & purification
  • Bifidobacterium / drug effects
  • Bifidobacterium / isolation & purification
  • Bifidobacterium / physiology*
  • Clindamycin / administration & dosage*
  • Clindamycin / adverse effects
  • Female
  • Humans
  • Intestines / drug effects*
  • Intestines / microbiology
  • Lactobacillus / drug effects
  • Lactobacillus / physiology
  • Lactobacillus acidophilus / drug effects
  • Lactobacillus acidophilus / isolation & purification
  • Lactobacillus acidophilus / physiology*
  • Male
  • Middle Aged
  • Probiotics / administration & dosage
  • Statistics, Nonparametric
  • Yogurt / microbiology

Substances

  • Anti-Bacterial Agents
  • Clindamycin